(Total Views: 315)
Posted On: 09/29/2019 6:44:33 AM
Post# of 150403
I no longer understand what is FDA problem , I don’t think there is any reasonable explanation for such a long delay of this medicine.
Ibalizumab efficacy was 43% , our 81% with 350 mg .why it was not approved then ...??
We didn’t have one serious side effect .
Ibalizumab - About 13% patient had side effects including dead , not necessarily due to medicine .
Ibalizumab efficacy was 43% , our 81% with 350 mg .why it was not approved then ...??
We didn’t have one serious side effect .
Ibalizumab - About 13% patient had side effects including dead , not necessarily due to medicine .
(0)
(0)Scroll down for more posts ▼
